Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X (DRIP)
DRIP price chart
DRIP fund facts
Returns and risk
Cost: expense ratio
We could not match an expense ratio for DRIP in the SEC prospectus data we read. Funds structured as trusts or notes, and very new funds, are often missing. We show nothing rather than a guess; the issuer's fact sheet has the figure.
Income: distributions
DRIP top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | DREYFUS | 61.19% |
| 2 | GOLDMAN FINANCIAL | 33.43% |
| 3 | DREYFUS | 10.75% |
| 4 | N/A | 0.36% |
| 5 | N/A | -0.27% |
| 6 | N/A | -0.31% |
| 7 | N/A | -1.24% |
| 8 | N/A | -2.50% |
Similar Leveraged ETFs
TSLR GraniteShares 2x Long TSLA Dai...0.95% fee · −46.9% 1y SNK GraniteShares 2x Short SpaceX...– 1y TECS Direxion Daily Technology Bear...−64.4% 1y SKHX Leverage Shares 2X Long SK Hyn...– 1y IREX Tradr 2X Long IREN Daily1.30% fee · – 1y YANG Direxion Daily FTSE China Bear...+61.9% 1y All leveraged ETFs →DRIP: frequently asked questions
What is DRIP?
DRIP is the Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF, issued by Direxion, listed on NYSE ARCA. By our rules it is classed as "Leveraged". Its latest SEC filing lists 8 holdings.
Does DRIP pay dividends?
Yes. DRIP paid 1.23 per share over the last 12 months, quarterly, a trailing yield of 3.97% on today's price. The latest ex-dividend date was 22 Sep 2026.
What does DRIP hold?
The largest holdings in the latest SEC filing are DREYFUS (61.2%), GOLDMAN FINANCIAL (33.4%), DREYFUS (10.8%). The top 10 together make up 101.4% of the fund.
How has DRIP performed?
Total return including distributions to 22 Oct 2026: 1 year −66.5%, 3 years −29.2% a year, 5 years −40.6% a year. Past performance does not guarantee future results.
Is DRIP leveraged?
By its name DRIP aims for -2x the daily return of its target. The multiple resets every day, so returns over weeks or months can differ a lot from the stated multiple, and losses can compound. Funds like this are designed for short holding periods.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.